Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
---|
03/13/2008 | US20080064874 2-Halofuryl/Thienyl-3-Carboxamides |
03/13/2008 | US20080064740 Novel Thiophene Derivatives |
03/13/2008 | US20080064733 MAGIs (membrane associated guanylate kinase proteins with inverse orientation); oncosuppressive (tumor suppressor) protein; (2-(1-Hydroxypentyl)-3-(2-phenylethyl)-6-methyl)indole-5-carboxylic acid |
03/13/2008 | US20080064730 Insecticide, nematocides and for arachnids |
03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
03/13/2008 | US20080064662 Agonists having a biphenyl moiety in combination with an amide linkage at the core of the structure enhances selectivity for S1P1 receptor without causing hypotension or bradycardia; transplant rejection, autoimmune diseases; 2-Amino-N-[4-(biphenyl-4-yloxy)-phenyl]3-hydroxy-2-methyl-propionamide |
03/13/2008 | CA2662091A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
03/13/2008 | CA2661102A1 Thiophene derivatives as s1p1/edg1 receptor agonists |
03/12/2008 | EP1897864A1 Anthracene derivatives and the use thereof for treating benign and malignant tumors |
03/12/2008 | EP1897550A2 Prodrugs of Excitatory Amino Acids |
03/12/2008 | EP1896461A2 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
03/12/2008 | EP1896446A1 Novel thiophene derivatives |
03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
03/12/2008 | CN101142205A Process for isomerization of 2-halothiophene to-3-halothiophene |
03/12/2008 | CN101142204A Improved process for the kumada coupling reaction |
03/12/2008 | CN101142172A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
03/12/2008 | CN101139338A Preparation of 2,2-disulfo-dibenzopyrene by oxygen process based on 2-mercaptan benzothiazole ammonia salt |
03/12/2008 | CN101139337A Novel method for preparing substituted thenoic acid ester and uses thereof |
03/12/2008 | CN101139309A Asymmetric star-radiation shaped triphenylamine compound and uses thereof |
03/12/2008 | CN101139267A White black falsehellebore alcohol derivative, analogue and preparation method and use thereof |
03/12/2008 | CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity |
03/12/2008 | CN100374433C Conductive organic compound and its electronic device |
03/12/2008 | CN100374416C P-(sulfonyl)-aryl and heteroaryls amines |
03/11/2008 | US7342116 Process for producing heterocyclic aldehyde |
03/11/2008 | US7342042 Lily of the valley aromachemicals |
03/11/2008 | US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis |
03/11/2008 | US7342013 Benzamides and related inhibitors of factor Xa |
03/11/2008 | CA2485298C Substituted pyrazolyl compounds for the treatment of inflammation |
03/11/2008 | CA2421880C Resorcinol derivatives |
03/11/2008 | CA2274954C Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient |
03/11/2008 | CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
03/06/2008 | WO2008026602A1 Heteroacene derivative, tetrahaloterphenyl derivative, and their production methods |
03/06/2008 | WO2008025694A1 Inhibitors for glyt-1 |
03/06/2008 | WO2008004191A3 Process for the preparation of enantiomerically pure salts of n-methyl-3- ( 1-naphthaleneoxy) -3- (2-thienyl) propanamine |
03/06/2008 | WO2007149829A3 Therapeutic compounds |
03/06/2008 | WO2007145835A3 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity |
03/06/2008 | WO2007102999A3 Cb1 antagonists and inverse agonists |
03/06/2008 | US20080058521 Processes for the preparation of compounds |
03/06/2008 | US20080058389 Carboxamides |
03/06/2008 | US20080058382 Polyamine compounds |
03/06/2008 | US20080058372 2,5-bis{[alkyl(or aryl)imino]aminophenyl}furans and thiophenes; "reversed" amidines; DNA-binding affinities; microbiocide; mycobacterial, fungal, protozoal infection; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp. |
03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
03/06/2008 | US20080058331 Inhibitors for GlyT-1 |
03/06/2008 | US20080058324 Alpha-Keto Carbonyl Calpain Inhibitors |
03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
03/06/2008 | US20080055701 First and second cathodic polymers switchable between a first color state and a second transparent state; monomers based on alkylenedioxythiophene; fluorinated electrochromic monomers and an electrochromic monomer with silicon; third color by subtractive color mixing of first and second cathodic polymers |
03/06/2008 | CA2661863A1 Inhibitors for glyt-1 |
03/05/2008 | EP1894923A1 Benzothiophene derivative and organic electroluminescence device making use of the same |
03/05/2008 | EP1893597A2 Ampa receptor potentiators |
03/05/2008 | EP1893596A2 Benzoýb¨furane and benzoýb¨thiophene derivatives |
03/05/2008 | EP1893568A2 Monoamine re-uptake inhibitors and methods relating thereto |
03/05/2008 | EP1893566A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
03/05/2008 | CN101137693A Semiconductors containing perfluoroether acyl oligothiophene compounds |
03/05/2008 | CN101137641A Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same |
03/05/2008 | CN101137640A Method for the representation of 3,3,4,4-tetrachlorotetrahydrothiophene-1,1-dioxide |
03/05/2008 | CN101134753A Method for preparing photochromic 1-thiophene2-phenyl six-membered ring series-parallel asymmetric perfluoro cyclopentene and use thereof |
03/04/2008 | US7338969 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants |
02/28/2008 | WO2008024746A1 4-substituted phenoxyphenylacetic acid derivatives |
02/28/2008 | WO2008024304A2 Compounds for treatment of proliferative disorders |
02/28/2008 | WO2008024302A2 Compounds for treating proliferative disorders |
02/28/2008 | WO2008023783A1 Amine compound |
02/28/2008 | WO2008023759A1 Aromatic amine derivatives and organic electroluminescence devices using the same |
02/28/2008 | WO2008023549A1 Aromatic amine derivatives and organic electroluminescent devices made by using the same |
02/28/2008 | WO2008022938A1 Di-aromatic substituted amides as inhibitors for glyt1 |
02/28/2008 | WO2008022467A1 2-substituted azain doles and 2 substituted thienopyrroles, their precursors and novel processes for the preparation thereof |
02/28/2008 | WO2008008701A3 Substituted cyclopentane derivatives as therapeutic agents |
02/28/2008 | WO2008008700A3 Substituted cyclopentane derivatives as therapeutic agents |
02/28/2008 | WO2007017510A3 Isophthalic acid diamides for treating alzheimer's disease |
02/28/2008 | US20080051374 ophthalmically acceptable for reducing intraocular pressure |
02/28/2008 | US20080050787 Method for Manufacturing Optically Active Tetrahydrothiophene Derivative and Method for Crystallization of Optically Active Tetrahydrothiophene-3-Ol |
02/28/2008 | US20080048181 Organic Semiconductor Thin Film, Organic Semiconductor Device, Organic Thin Film Transistor and Organic Electronic Luminescence Element |
02/28/2008 | CA2661459A1 Di-aromatic substituted amides as inhibitors for glyt1 |
02/28/2008 | CA2661440A1 Compounds for treating proliferative disorders |
02/28/2008 | CA2661164A1 4-substituted phenoxyphenylacetic acid derivatives |
02/28/2008 | CA2660531A1 Compounds for treatment of proliferative disorders |
02/27/2008 | EP1891951A1 Viral polymerase inhibitors |
02/27/2008 | EP1891950A1 Viral polymerase inhibitors |
02/27/2008 | EP1891073A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
02/27/2008 | EP1891028A1 Non-peptidic inhibitors of akap/pka interaction |
02/27/2008 | EP1737868B1 Stereoselective method for the production of clopidogrel |
02/27/2008 | EP1615904B1 Substituted benzosulphonamides as potentiators of glutamate receptors |
02/27/2008 | EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors |
02/27/2008 | EP1399423B9 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds |
02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
02/27/2008 | CN101133060A Enzyme inhibitors |
02/27/2008 | CN101133011A Process for the manufacture of substituted propionic acids |
02/27/2008 | CN100371324C Dialkyl and diaryl tetrasubstituted heterocyclic compounds, preparing process and use thereof |
02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
02/26/2008 | US7335779 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent |
02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
02/26/2008 | US7335673 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
02/26/2008 | US7335666 That inhibit serotonin reuptake and are antagonists of the 5HT1A receptor; 2-[3-(6-Fluoro-indol-1-ylmethyl)-azetidin-1-ylmethyl]-8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinoline for example |
02/21/2008 | WO2008020939A2 Phenylalkyl n-hydroxyureas for combating atherosclerotic plaque |
02/21/2008 | WO2008020045A1 Tetrahydrobenzothiophene derivatives |
02/21/2008 | WO2008019690A1 Substituted acetylenic compounds useful for the treatment of diseases |
02/21/2008 | WO2008019477A1 Viral polymerase inhibitors |
02/21/2008 | WO2007103456A3 Piperazine and piperidine biaryl derivatives |
02/21/2008 | US20080045545 3-{[(4-pyrazol-1-yl-benzyl)-(pyridine-3-sulfonyl)-amino]methyl}phenoxy)-acetic acid isopropyl ester; for reducing intraocular pressure in treating glaucoma, in a mammal |
02/21/2008 | US20080045483 such as 4-{2-[2-(4-chlorobenzenesulfonylamino)phenyl]ethyl}benzoic acid; hyperglycemic agents |